Key result
PCI shows no benefit over optimal therapy for 12-month angina recurrence in intermediate coronary lesions.
Why the study?
Functional and morphological criteria for myocardial revascularization in patients with intermediate coronary stenosis require comparison to guide treatment decisions.
Does percutaneous coronary intervention guided by functional or morphological assessment reduce recurrence of angina, myocardial infarction, all-cause mortality and target vessel revascularization compared to optimal therapy in patients with intermediate coronary artery stenosis?
Cohort (n=49)
Does percutaneous coronary intervention guided by functional or morphological assessment reduce recurrence of angina, myocardial infarction, all-cause mortality and target vessel revascularization compared to optimal therapy in patients with intermediate coronary artery stenosis?
In patients with intermediate coronary stenosis, PCI guided by intravascular physiology or imaging did not significantly reduce angina recurrence at 12 months compared to optimal medical therapy.
PCI showed no angina benefit over optimal therapy in intermediate lesions; leaves open whether functional guidance improves outcomes in RCTs.
Objective. To compare functional and morphological indications for myocardial revascularization in patients with intermediate lesions of coronary arteries. Material and methods. Patients with coronary artery disease underwent functional (FFR/iFR) and morphological (OCT/IVUS) assessment of intermediate stenosis 40—70% (by diameter) to identify significance of lesions. Percutaneous coronary intervention was performed if indications for revascularization were identified according to one method. After 12 months, the following endpoints were assessed: recurrence of angina, myocardial infarction, all-cause mortality and target vessel revascularization. Results. The study included 49 patients with intermediate coronary artery stenosis. Coincidence of functional and morphological criteria was observed in 69% of cases. In 12% of patients, significant stenoses were detected by FFR in contrast to intravascular imaging. In 19% of patients, there were morphological criteria of significance, but hemodynamic effect of lesion was not confirmed by intravascular physiology. After 12 months, there was no significant difference in angina recurrence rate between groups of PCI and optimal therapy (8.3% and 4%, p=0.793). Conclusion. Thus, determining the strategy under control of intracoronary physiology and imaging allows us to identify functional and morphological criteria for revascularization. In turn, FFR/iFR was associated with lower frequency of detection of criteria for significance of intermediate lesions compared to IVUS/OCT. Percutaneous coronary intervention or avoiding revascularization in favor of optimal therapy did not demonstrate differences in the incidence of endpoints after a year.
No takes yet. Share an insight, caveat, or question.
Arnt et al. (2025) conducted a cohort in Coronary artery disease with intermediate coronary stenosis (n=49). Percutaneous coronary intervention vs. Optimal therapy was evaluated on Recurrence of angina (p=0.793). Percutaneous coronary intervention did not significantly differ from optimal therapy in the 12-month incidence of angina recurrence (8.3% vs 4%, p=0.793) for intermediate coronary lesions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: